Keto keeps getting pulled into a food fight it did not start, and that is exactly why the science needs a cooler read. New Scientist’s core argument is blunt: a controversial audience does not invalidate a line of inquiry, and the ketogenic diet is now too interesting to dismiss with guilt by association. The real test is whether the data can stand up on its own.
Why association is the wrong test
The loudest version of the keto debate is not about ketones, seizure control, or mood scores. It is about who happens to amplify the idea, which is how researchers studying ketogenic therapy for mental health can end up awkwardly linked with Robert F. Kennedy Jr. That kind of political contamination makes for easy outrage, but it tells you almost nothing about whether the underlying biology is worth studying.
That is the point New Scientist presses hardest: controversial people can latch onto a serious idea, and the idea does not automatically become unserious because of that. For keto readers, that matters because the diet now sits in a space where metabolism, brain health, and psychiatry overlap. If you care about this field, you need a better filter than tribal instinct.
Keto’s medical history is older than the culture war
This is not a brand-new wellness trend that wandered in from social media. The ketogenic diet was developed in 1921 at the Mayo Clinic by Dr. Russell Wilder as a treatment for refractory epilepsy, after early work showed ketosis could mimic fasting-related seizure control. For more than a century, keto has remained a standard non-pharmacologic option for drug-resistant epilepsy, and that history is why serious researchers still take it seriously.
That origin story matters because it shows how an unpopular or unconventional idea can survive repeated scrutiny. Keto did not earn a place in neurology by being trendy. It earned a place because it produced a repeatable clinical effect in a population with few good options.
What the mental health evidence actually shows
The modern excitement is not coming from weight-loss marketing. It is coming from small but real signals in psychiatric research, especially where metabolic dysfunction seems to overlap with symptoms. In a 2024 Stanford Medicine pilot trial, 21 adults with schizophrenia or bipolar disorder and a metabolic abnormality followed a ketogenic diet for four months, and most reportedly showed improvements in both psychiatric symptoms and metabolic measures.
That is encouraging, but it is still a pilot trial, not the finish line. Stanford also said it was recruiting for a larger randomized controlled trial on ketogenic therapy for schizophrenia, bipolar disorder, and depression, which is exactly the sort of next step the field needs. The same research stream is expanding into depression, anorexia nervosa, bipolar disorder, ADHD, and Alzheimer’s disease, but those studies are still part of an emerging picture, not a settled verdict.
A 2025 JAMA Psychiatry systematic review and meta-analysis gives the debate more structure. It examined 50 studies and found ketogenic diets were associated with small-to-moderate improvements in depressive symptoms in randomized clinical trials, with larger improvements in quasi-experimental studies. The catch is the one that matters most: the review still said the therapeutic value in psychiatric populations remains uncertain.
That combination, signal plus uncertainty, is where keto currently lives. There is enough evidence to justify serious study, but not enough to turn the diet into a cure-all or to let advocates outrun the data.
Where the hype line gets crossed
The public conversation got noisier in February 2026, when Robert F. Kennedy Jr. claimed keto could cure schizophrenia. That was the kind of statement that drags a nuanced research field straight into the mud. Harvard psychiatrist Christopher M. Palmer said Kennedy overstated the science, and AFP reported that experts said the comments went far beyond what the current evidence supports.
This is the trap keto readers should know by heart. Weak evidence gets inflated into certainty, critics overreact, and the middle gets lost. The middle is where the actual science lives: preliminary, intriguing, and not remotely ready for miracle language.
How to judge the next keto claim without joining a diet war
If you want a practical lens, use one that rewards structure over slogans.
- Ask whether the claim rests on randomized trials or only on anecdote, pilot data, or metabolic theory.
- Check the sample size and duration. Twenty-one adults over four months is useful; it is not the same thing as a large, long-term controlled trial.
- Look at the outcome. Improvement in mood, symptoms, or metabolic markers is not the same as cure, and it is not the same as prevention.
- Separate feasibility from efficacy. A diet can be safe and tolerable in a small study without proving it works broadly.
- Notice whether the population is well-defined. The evidence is most interesting where participants have a clear diagnosis and, in some cases, a metabolic abnormality.
- Pay attention to the comparison group. Quasi-experimental results can point the way, but randomized trials are what harden a claim into something clinically credible.
That lens is especially important as research moves into anorexia nervosa and other neuropsychiatric questions. NIH RePORTER shows a project on ketogenic diet use in weight-recovered anorexia nervosa aimed at safety, tolerability, and target engagement, and a 2026 PubMed-indexed study evaluated a 14-week weight-maintaining ketogenic dietary therapy in adults with anorexia nervosa. Those are exactly the kinds of studies that can either strengthen the case or expose the limits.
The real standard keto has to meet
The strongest argument for keto is not that it is fashionable, or that its enemies are obnoxious, or that some public figures are talking too loudly. The strongest argument is that a century-old therapy for refractory epilepsy has generated enough new signal in psychiatry to justify careful, disciplined testing. If future trials keep showing consistent benefits in depression, schizophrenia, or related conditions, the field gets stronger. If larger studies wash out the early effects, then the hype dies for a reason that actually matters.
That is the standard New Scientist is pushing, and it is the right one for keto too. Do not dismiss the science because the neighbors are noisy, but do not confuse noisy attention with proof.
Every story on Keto Diet Magazine is assembled by an automated editorial system that works from verified research, official records, and credible reporting, then clears automated accuracy and moderation checks before it goes live. The standards that system follows are set and overseen by the people who run the publication. Read our full editorial policy.
Know something we missed? Have a correction or additional information?
Submit a Tip
